文献速递重症综合管理与镇静镇痛

右美托咪定使用增加后ICU镇静结局的评估

Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU.
PubMed 文献 · Crit Care Explor · 2020-04-29
一句话结论放宽右美托咪定处方指南后其使用率从13.8%升至51.9%,但机械通气时长无差异。

该单中心回顾性病历审查比较了右美托咪定处方指南更新前后ICU接受持续输注镇静药或阿片类药物患者的镇静实践。PRE组(2016年9–11月)217例,POST组(2017年9–11月)210例。右美托咪定使用率由13.8%升至51.9%(p<0.001),但机械通气中位时长PRE 49小时(24–110小时)vs POST 47.5小时(26–98小时)(p=0.8),ICU住院时长与医院住院时长均无显著差异;控制混杂因素后通气时间仍无变化(p=0.98)。

要点

  • 放宽右美托咪定处方指南后,ICU encounters中使用率由13.8%升至51.9%(p<0.001),但机械通气中位时长PRE 49小时(24–110小时)vs POST 47.5小时(26–98小时)(p=0.8)。
  • ICU住院时长中位数PRE 136小时 vs POST 121小时(p=0.2),医院住院时长中位数PRE 296小时 vs POST 326小时(p=0.35),均无显著差异。
  • 控制可能混杂因素后,PRE与POST之间通气时间仍无变化(p=0.98)。
  • 研究排除了机械通气<12小时、急性神经损伤、烧伤>20%体表面积、慢性气管造口、神经科学或心脏外科ICU、ECMO支持及接受神经肌肉阻滞剂输注的患者。
  • 多数被排除患者因入住神经科学或心脏外科ICU而被排除。

适用人群与场景

  • 纳入:2016年9–11月(PRE)和2017年9–11月(POST)入住ICU并开具持续输注镇静药或阿片类药物医嘱的患者。
  • 排除:机械通气<12小时、急性神经损伤入院、烧伤>20%体表面积、慢性气管造口、入住神经科学或心脏外科ICU、接受ECMO支持、接受神经肌肉阻滞剂输注的患者。

研究设计与关键结果

  • 研究类型:单中心回顾性病历审查,三级学术医学中心。
  • 共评估1426例,427例符合标准:PRE组217例,POST组210例;多数患者因入住神经科学或心脏外科ICU被排除。
  • 右美托咪定使用率:PRE组13.8% vs POST组51.9%(p<0.001)。
  • 机械通气中位时长:PRE组49小时(24–110小时)vs POST组47.5小时(26–98小时)(p=0.8)。
  • ICU住院时长中位数:PRE组136小时 vs POST组121小时(p=0.2)。
  • 医院住院时长中位数:PRE组296小时 vs POST组326小时(p=0.35)。
  • 控制可能混杂因素后,PRE与POST之间通气时间无变化(p=0.98)。

证据类型、等级与局限

  • 证据类型:单中心回顾性病历审查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:扩大医院右美托咪定处方指南导致右美托咪定使用增加,但与机械通气时长差异无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To evaluate sedation practices following a dexmedetomidine guideline update in the ICU.

DESIGN: Single-center, retrospective chart review.

SETTING: Tertiary academic medical center.

PATIENTS: Patients were included in this analysis if they were admitted to the ICU and were ordered for continuous infusion sedatives or opioids from September to November 2016 (PRE) and from September to November 2017 (POST). Patients were excluded from this analysis if they met any of the following criteria: mechanical ventilation less than 12 hours, admitted with acute neurologic injury, burn of greater than 20% total body surface area, chronic tracheostomy, admitted to the neuroscience or cardiac surgery ICU, on extracorporeal membrane oxygenation support, or received an infusion of neuromuscular blockers.

INTERVENTIONS: Patients admitted during a restricted dexmedetomidine prescribing guideline were compared with patients admitted during an expanded prescribing guideline.

MEASUREMENTS AND MAIN RESULTS: Of the 1,426 patients evaluated for inclusion, 427 patients met the criteria in this analysis. Of these, 217 patients were in the PRE and 210 patients in the POST. A majority of patients were excluded for admission to neuroscience or cardiac surgery ICU. Dexmedetomidine was used in 13.8% of encounters in the PRE and 51.9% of encounters in the POST (p < 0.001). The median duration of mechanical ventilation was 49 hours (24-110 hr) in the PRE and 47.5 hours (26-98 hr) in the POST (p = 0.8). ICU length of stay was a median of 136 and 121 hours in the PRE and POST, respectively (p = 0.2). The median hospital length of stay was 296 and 326 hours in the PRE and POST, respectively (p = 0.35). After controlling for possible confounders, ventilation time remained unchanged between the PRE and POST (p = 0.98).

CONCLUSIONS: The expansion of a hospital dexmedetomidine prescribing guideline resulted in an increased use of dexmedetomidine but was not associated with a difference in length of mechanical ventilation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Schuler BR, Kovacevic MP, Dube KM, et al. Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU. Crit Care Explor. 2020. PMID: 32426742. doi:10.1097/CCE.0000000000000100

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。